Ribophorin II (RPN2), a part of the N-oligosaccharyltransferase complex, promotes breast cancer malignancy by regulating the glycosylation of tetraspanin protein CD63 and multidrug resistance protein 1 (MDR1). This evidence concerns the gene RPN2 and breast carcinoma.